Chemical coding of piglets small intestine neurons after prenatal exposure to β-hydroxy-β-methylbutyrate
Published Online: Apr 19, 2025
Page range: 249 - 255
Received: Nov 11, 2024
Accepted: Apr 01, 2025
DOI: https://doi.org/10.2478/jvetres-2025-0024
Keywords
© 2025 Aleksandra Dajnowska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
To achieve high pork production efficiency and generate significant economic profits, the global swine industry must confront numerous challenges. These include the need to optimise nutrition, implement effective disease control and prevention measures, maintain proper hygiene and safety, and address issues such as extreme temperature fluctuations and low survival rates among newborn piglets (8, 24). The latter issue is closely linked to the optimisation of nutrition, which, beyond its obvious benefits in pig production, can also help address piglets’ general health status (18). The optimal nutrition of pregnant sows with a diet that is properly balanced and rich in key nutrients significantly improves reproductive performance, birth litter weight, weaning weight and the survival rate of newborn piglets. The composition of colostrum and milk is regulated by the mother’s diet, which directly influences the maturation of the newborns’ immune systems, providing protection against infections and supporting the development of a healthy gut microbiome. Overall intestinal health is, in turn, extremely important in combating piglet weaning stress, which is often combined with diarrhoea (11). However, the shaping of the offspring’s health starts earlier, in prenatal life. The prenatal programming theory states that postnatal development is shaped not only by genetics but also by prenatal non-genetic factors, such as the nutrients present in the pregnant female’s diet (2). One supplement that has been successfully used in prenatal nutritional programming is β-hydroxy-β-methylbutyrate (HMB) (26). This metabolite of leucine is commonly used as a dietary supplement to support protein metabolism, insulin activity and skeletal muscle hypertrophy. It is particularly popular among athletes and physically active individuals. In animals, HMB supplementation has shown various benefits, particularly in livestock, where it primarily leads to increased weight gain and improved production yields (29). Studies on pigs have demonstrated that HMB supplementation in sows’ diets as part of nutritional programming leads to heavier newborn piglets and faster attainment of market weight, because more protein is synthesised in the piglets’ skeletal muscles. Positive effects on the development of the offspring’s skeletal and digestive systems have also been observed (2, 5, 27). Additionally, it was noted that HMB may improve the uniformity of piglet birth weights, potentially mitigating the effects of intrauterine growth restriction (3).
As noted earlier, gut health plays a vital role in piglet development. The enteric nervous system (ENS), a key part of the digestive tract, is crucial for the early development of digestive functions. Intestinal innervation starts prenatally and continues to mature after birth, which is essential for newborn piglets as they transition to solid food (13). It is already known that HMB supplementation in pregnant sows significantly affects the expression of leptin, vasoactive intestinal peptide (VIP), and other gut barrier proteins in the offspring during weaning, while having a lesser impact on the basic morphology of the small intestine (26). There is presently insufficient data on the effect of HMB on the prenatal development of small intestine innervation in newborn pigs. Consequently, it is not known whether the effects observed by Tomaszewska
Throughout the entire experiment, the health of both pregnant sows and newborn piglets was closely monitored by a veterinarian. Regular veterinary care ensured the welfare of the animals and eliminated any undesirable factors that could affect the course of the experiment. Additionally, this study complied with the requirements of Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes, and was approved by the Local Ethics Committee for Animal Experiments at the University of Life Sciences in Lublin (protocol No. 2014/29).
The study involved 24 piglets born from 12 healthy primiparous sows of the Large White Polish breed, approximately 10 months old. A dose of 0.2 g/kg of body weight (b.w.) of HMB (Lonza, Basel, Switzerland) was administered with the morning meal to six randomly selected sows daily from the 70th to 90th day of gestation. The supplementation period and HMB dose were selected based on previous studies (23, 25). The remaining six sows were fed a standard diet. Both groups of sows were housed in standard conditions with controlled diets, including balanced commercial feed for pregnant and lactating sows, provided in the amount of 3.0 kg of feed mixture per sow, with water given
Ten-millimetre fragments of the small intestine (the duodenum, jejunum and ileum) were collected from each piglet. The tissues were fixed and immunohistochemical reactions were conducted according to a previously described protocol (4). The antibodies used in the study are described in Table 1.
Primary and secondary antibodies used in the study
Antibody | Host | Catalogue number | Dilution | Manufacturer |
---|---|---|---|---|
Primary antibody | ||||
anti-VIP | rabbit | ab22736 | 1:400 | Abcam Limited, Cambridge, UK |
anti-CART | rabbit | H-003-62 | 1:2,000 | Phoenix Pharmaceuticals, Burlingame, CA, USA |
anti-nNOS | rabbit | 160870 | 1:200 | Cayman Chemical, Ann Arbor, MI, USA |
anti-SP | mouse | ab14184 | 1:1,000 | Abcam Limited, Cambridge, UK |
Secondary antibody | ||||
anti-mouse/anti-rabbit | goat | DPVB-HRP | RTU | ImmunoLogic, Duiven, the Netherlands |
VIP – vasoactive intestinal peptide; CART – cocaine-and-amphetamine-regulated transcript; nNOS – neuronal nitric oxide synthase; SP – substance P;
HRP – horseradish peroxidase-conjugated; RTU – ready to use
The sections were examined under a light microscope (BX-51 DSU; Olympus, Tokyo, Japan) equipped with a digital camera (DP-70; Olympus) at magnifications of 10×, 20× and 40×. No positive immunoreactivity was observed on any of the slides subjected to the negative control reaction. High-resolution digital images were taken, all by a single person, using Cell^M 2.3 in cellSens Standard software (Olympus) under consistent lighting conditions and uniform brightness and contrast settings. Surface area analysis of nerve fibres was performed using ImageJ version 1.54f software (20), including measurements of the area of CART-, nNOS-, SP- and VIP-immunoreactive nerve fibres across the entire cross-section of the duodenum, jejunum and ileum from each piglet in the experimental group (n = 12) and in the control group (n = 12). The area of nerve fibres immunoreactive to nNOS, SP, CART and VIP was expressed as the ratio of the area occupied by the fibres in μm2 to 100 μm2 of the intestinal cross-section.
To assess the effect of HMB supplementation on the chemical coding of the small intestine ENS in piglets, a statistical analysis of the obtained results was performed. Student’s
A statistically significant increase in the area of CART-reactive fibres in this tissue was observed in the group of piglets supplemented with HMB compared to the control group (P-value < 0.001). However, a significant decrease in the area was noted for SP- and VIP-reactive fibres in the experimental group, with P-values of 0.002 and <0.001, respectively. No significant difference was found in the area of nNOS-reactive fibres (P-value = 0.240) between the groups.
In the submucosa of the duodenum, a significantly smaller area of VIP-reactive fibres (P-value < 0.001) was noted in the experimental group of piglets, with no significant changes in the area of CART-, SP- or nNOS-reactive fibres (P-values of 0.201, 0.732, and 0.100, respectively) compared to the control group.
A significant contraction of the area of CART-, SP- and VIP-reactive fibres was seen in the experimental group of piglets (P-value < 0.001 each). Additionally, a significant expansion of the area of nNOS-reactive fibres (P-value < 0.001) was observed in the same group compared to the control group.
This tissue presented a statistically significantly lesser area of SP-, VIP- and nNOS-reactive fibres in the experimental group of piglets, with P-values of 0.002, <0.001 and 0.039, respectively. However, no significant difference was found in the area of CART-reactive fibres (P-value = 0.187) compared to the control group.
In the submucosa of the jejunum, the area of VIP- and nNOS-reactive fibres (P-value < 0.001 each) was observed to be significantly smaller in the experimental group of piglets, while no significant differences were found between the areas of CART- or SP-reactive fibres (P-values of 0.337 and 0.224, respectively) and those of the control group.
In these sections, the CART-(P-value < 0.001), SP-(P-value = 0.001) and VIP-reactive fibres (P-value = 0.002) extended over less area in the experimental group of piglets, while the area of nNOS-reactive fibres occupied more tissue than in the control group (P-value < 0.001).
The muscular layer of the ileum revealed a significant increase in the area of CART-reactive fibres (P-value < 0.001) in the experimental group of piglets, along with a significant decrease in the area of SP- and VIP-reactive fibres (P-values of 0.017 and <0.001, respectively). No significant difference was found in the area of nNOS-reactive fibres (P-value = 0.280) between the experimental and control groups.
The experimental group of piglets’ submucosa of the ileum presented a significantly larger area of CART-reactive fibres (P-value = 0.015) and a significantly smaller one of VIP-reactive fibres (P-value = 0.004), but displayed areas of SP- and nNOS-reactive fibres not significantly different (P-values of 0.128 and 0.113, respectively) from those of the control group.

Prenatal effect of β-hydroxy-β-methylbutyrate (HMB) supplementation on the area occupied by cocaine-and-amphetamine-regulated transcript (CART)-immunoreactive (IR), substance P (SP)-IR, vasoactive intestinal peptide (VIP)-IR, and neuronal nitric oxide synthase (nNOS)-IR nerve fibres in the muscular layer of the duodenum, jejunum and ileum (a, b and c), the submucosa of the duodenum, jejunum and ileum (d, e and f), and the mucosa of the duodenum, jejunum and ileum (g, h and i) in newborn piglets prenatally supplemented with HMB and control piglets. * – significant difference between the control and HMB groups at P-value < 0.05; ** – at P-value < 0.01; *** – at P-value < 0.001

Representative photomicrographs of the immunohistochemical reactions for cocaine-and-amphetamine-regulated transcript (CART) (A and B), substance P (SP) (C and D), vasoactive intestinal peptide (VIP) (E and F) and neuronal nitric oxide synthase (nNOS) (G and H) in the duodenum (A, B, E and F) and jejunum (C, D, G and H) of control (A, C, E and G) and prenatally HMB-exposed (B, D, F and H) piglets. Arrow – positive reaction. Scale bar = 200 μm
Sections of the mucosa of the ileum were noted to have a significant decrease in the area of SP-(P-value < 0.001) and VIP-reactive fibres (P-value < 0.001) and a significant increase in the area of nNOS-reactive fibres (P-value = 0.002) in the experimental group of piglets compared to the control group.
The present study investigated the effects of prenatal HMB supplementation on the chemical coding of the ENS in the small intestine of neonatal piglets, focusing on the immunoexpression of VIP, CART, nNOS and SP peptides. There is limited information regarding how HMB influences the prenatal development of intestinal innervation, and whether the changes observed in previous studies manifest from birth. The results of the conducted study confirmed the initial assumption that prenatal HMB supplementation would affect the chemical coding of the ENS.
One of the most consistent findings across intestinal regions and layers was the significant decrease in VIP- and SP-reactive fibres in piglets prenatally supplemented with HMB, especially in the muscular layers and mucosa. These neuropeptides play critical roles in the regulation of intestinal motility, secretion and inflammation (15). Vasoactive intestinal peptide acts neuroprotectively and to counter inflammation, reducing the expression of pro-inflammatory cytokines and enlarging the production of anti-inflammatory cytokines (21). It also participates in the modulation of intestinal motility and blood flow (19), which affects digestion and protects the intestines from inflammatory conditions (6). Substance P, another neuropeptide, is in the tachykinin family and acts as a neurotransmitter and neuromodulator in the gastrointestinal tract (12). It modulates immune, vascular and motor responses and serves as a pro-inflammatory mediator by activating immune cells like mast cells, macrophages and T cells
There is a similar study that seemingly contradicts our results. Tomaszewska
In comparison to SP- and VIP-reactive fibres, CART-reactive fibres extended over significantly more of the duodenal and ileal muscular layer and ileal submucosa areas. Cocaine-and-amphetamine-regulated transcript, known to be involved in regulating appetite and energy homeostasis, has been less studied in the context of the ENS (30). The proliferation of CART-reactive fibres suggests that HMB might influence the energy regulatory mechanisms of the gut (16), possibly improving nutrient absorption or promoting energy efficiency in neonatal piglets. Fibres reactive with nNOS also showed interesting patterns, particularly in the mucosa, where there was a consistent increase across all intestinal regions. Neuronal NOS is a marker for nitrergic neurons, which are essential for smooth muscle relaxation and regulation of intestinal motility
Studies describing the impact of the toxin fumonisin and the toxic substance bisphenol A on the expression of the neuropeptides we investigated showed results opposite to ours, namely an increase in VIP- and SP-positive fibres and a decrease in CART- and nNOS- positive fibres (10, 23). In contrast, HMB as a supplement appears to regulate the expression of these neurotransmitters, which may indicate its protective effects. The decrease in SP and VIP levels following HMB administration could suggest a reduction in inflammation and an improvement in intestinal function, contrasting with the effect of toxins and toxic substances, which potentiates the activity of these peptides in response to the resultant damage (10, 22). The response to HMB supplementation varied across different regions of the small intestine. In the duodenum, a significant accrual of CART-reactive fibres in the muscular layer and a significant reduction in VIP-reactive fibres in both the submucosa and mucosa indicate a strong modulatory effect of HMB on the upper intestinal segments. In the ileum, however, HMB supplementation resulted in a marked increase in both CART-reactive fibres and nNOS-reactive fibres in the mucosa, suggesting that the effects of HMB may intensify towards the distal small intestine.
These regional differences could reflect the varying functional roles of the small intestine. The duodenum is primarily responsible for the initial stages of digestion and absorption, while the ileum plays a key role in the absorption of bile acids, vitamin B12 and other nutrients (9). The increased presence of CART and nNOS in the ileum might suggest a role for HMB in enhancing nutrient absorption and modulating motility towards the distal regions of the gut, where nutrient content is lower and energy absorption may be more critical. These findings provide new insights into how prenatal HMB supplementation may shape the development of the ENS and, by extension, gastrointestinal function in neonatal piglets. The reduction in SP- and VIP-reactive fibres, alongside the accrual of CART- and nNOS-reactive fibres, suggests that HMB exerts a selective influence on neurochemical pathways involved in gut motility, energy regulation and possibly immune function.
The beneficial effects of HMB on muscle preservation, immune modulation and anti-inflammatory responses in other tissues are known (1). The observed changes may reflect similar protective effects, potentially safeguarding the developing gut from inflammatory or oxidative damage during critical stages of growth. This could be particularly important for neonatal animals, as early-life gastrointestinal development has long-term consequences for health and productivity (31). However, the mechanisms by which HMB influences ENS development remain speculative. Further research is needed to elucidate the molecular pathways involved, potentially including interactions with growth factors, inflammatory mediators and oxidative stress responses, which are known to play a role in gut development and health.